IFF Announces Sale of its Pharma Solutions Business to Roquette for an Enterprise Value of up to $2.85B
Portfolio Pulse from Benzinga Newsdesk
IFF has agreed to sell its Pharma Solutions business to Roquette for up to $2.85 billion, with an enterprise value to EBITDA multiple of approximately 13x. The sale includes the Global Specialty Solutions business and is aimed at aligning customers, businesses, and manufacturing footprint.
March 19, 2024 | 10:48 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
IFF's sale of its Pharma Solutions business to Roquette for up to $2.85 billion could lead to a strategic realignment and potential financial strengthening.
The sale of IFF's Pharma Solutions business for a significant amount suggests a strategic move to streamline its operations and focus on core areas. The transaction's size and the involved parties indicate a positive outlook for IFF's financial health and strategic positioning in the market.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90